S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention
JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2023-11 · 21 (11) · 1422-1433
DOI: 10.1111/ddg.15256 ↗Kurz gefasst
Leitlinie in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 15.10.2023. Verfasst von Ulrike Leiter und 49 weiteren Autor:innen. Beteiligte Einrichtung: Center of Dermatooncology, University Department of Dermatooncology, Eberhard-Karls-University Tuebingen, Tübingen, Germany. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Keratosis, Actinic, Skin Neoplasms, Bowen's Disease. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Actinic keratosis (AK) are common lesions in light‐skinned individuals that can potentially progress to cutaneous squamous cell carcinoma (cSCC). Both conditions may be associated with significant morbidity and constitute a major disease burden, especially among the elderly. To establish an evidence‐based framework for clinical decision making, the guideline “actinic keratosis and cutaneous squamous cell carcinoma” was updated and expanded by the topics cutaneous squamous cell carcinoma in situ (Bowen's disease) and actinic cheilitis. The guideline is aimed at dermatologists, general practitioners, ear nose and throat specialists, surgeons, oncologists, radiologists and radiation oncologists in hospitals and office‐based settings, as well as other medical specialties, policy makers and insurance funds involved in the diagnosis and treatment of patients with AK and cSCC. A separate guideline exists for patients and their relatives. In this part, we will address aspects relating to epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center of Dermatooncology, University Department of Dermatooncology, Eberhard-Karls-University Tuebingen, Tübingen, Germany.
- Department of Dermatology, Uniklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
- Comprehensive Cancer Center Erlangen-European Metropolitan Area of Nuernberg, (CCC ER-EMN), Erlangen, Germany.
- Department of Dermatology, Johannes Wesling Medical Center, Ruhr University Bochum Campus Minden, Minden, Germany.
- Department of Dermatology, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
- Department of Dermatology, Venerology, and Allergology, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany.
Zitieren
APA
Leiter, U., Heppt, M. V., Steeb, T., Alter, M., Amaral, T., Bauer, A., Bechara, F. G., Becker, J. C., Breitbart, E. W., Breuninger, H., Diepgen, T., Dirschka, T., Eigentler, T., ElGammal, A. K. S., Felcht, M., Flaig, M. J., Follmann, M., Fritz, K., Grabbe, S., …, & Berking, C. (2023). S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 21(11), 1422-1433. https://doi.org/10.1111/ddg.15256
Vancouver
Leiter U, Heppt MV, Steeb T, Alter M, Amaral T, Bauer A, et al. S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2023;21(11):1422-1433. doi:10.1111/ddg.15256
BibTeX
@article{Leiter2023,
author = {Leiter, Ulrike and Heppt, Markus V and Steeb, Theresa and Alter, Mareike and Amaral, Teresa and Bauer, Andrea and Bechara, Falk G and Becker, Jürgen C and Breitbart, Eckhard W and Breuninger, Helmut and Diepgen, Thomas and Dirschka, Thomas and Eigentler, Thomas and ElGammal, A K Stephan and Felcht, Moritz and Flaig, Michael J and Follmann, Markus and Fritz, Klaus and Grabbe, Stephan and Greinert, Rüdiger and Gutzmer, Ralf and Hauschild, Axel and Hillen, Uwe and Ihrler, Stephan and John, Swen Malte and Kofler, Lukas and Koelbl, Oliver and Krause-Bergmann, Albrecht and Kraywinkel, Klaus and Krohn, Steffen and Langer, Thomas and Loquai, Carmen and Löser, Christoph R and Mohr, Peter and Nashan, Dorothée and Nothacker, Monika and Pfannenberg, Christina and Salavastru, Carmen and Schmitz, Lutz and Stockfleth, Eggert and Szeimies, Rolf-Markus and Ulrich, Claas and Voelter-Mahlknecht, Susanne and Vordermark, Dirk and Weichenthal, Michael and Welzel, Julia and Wermker, Kai and Wiegand, Susanne and Garbe, Claus and Berking, Carola},
title = {S3 guideline „actinic keratosis and cutaneous squamous cell carcinoma“ – update 2023, part 2: epidemiology and etiology, diagnostics, surgical and systemic treatment of cutaneous squamous cell carcinoma (cSCC), surveillance and prevention},
journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
year = {2023},
volume = {21},
number = {11},
pages = {1422--1433},
doi = {10.1111/ddg.15256}
}
EUVIMED